Cell responses to bone morphogenetic proteins and peptides derived from them: Biomedical applications and limitations |
| |
| Authors: | H H E O D E F S G N |
| |
| Institution: | aDepartment of Chemical Engineering and Biotechnological Engineering, Université de Sherbrooke, QC, Canada;bCentre de Recherche Clinique Étienne-Lebel, Université de Sherbrooke, QC, Canada;cDepartment of Orthopaedic Surgery, Université de Sherbrooke, QC, Canada;dProgram of Cellular Biology, Université de Sherbrooke, Sherbrooke, QC, Canada |
| |
| Abstract: | The bone morphogenetic proteins (BMPs) are cytokines of the transforming growth factor beta family. Some BMPs such as BMP-2 and BMP-7 play a major role in the development of the skeleton and the maintenance of homeostasis during bone remodelling. To date, only BMP-2 and BMP-7 have been approved by the Food and Drug Administration for specific orthopaedic applications. However, due to BMP cost, peptides derived from their knuckle epitope with osteogenic properties have been developed. BMPs are involved in many other biological events, including embryogenesis, angiogenesis and cancer. BMPs therefore have great biomedical potential as osteogenic factors and as anti-cancer agents. This review focuses on the use of BMPs and their derived peptides in biomedical delivery systems and gene therapy. |
| |
| Keywords: | Osteoblast Osteoclast Stem cell Osteosarcoma Delivery system |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
